期刊文献+

从组胺H_3受体的配体开发新药的展望 被引量:1

The histamine H_3 receptor ligands: potential therapeutic uses
下载PDF
导出
摘要 近年通过克隆技术鉴定了组胺H3和H4亚型受体。H3受体是突触前受体,其功能为调节组胺的生物合成与从末梢释放。在其他神经元也有H3受体的存在,因而还能调节其他若干神经递质的释放。已经发现了一些H3受体的激动剂与拮抗剂。实验研究表明这些激动剂与拮抗剂有广泛的生物作用。迄今尚未有这类化合物经批准在临床应用,但从其功用来日可能开发出一些有效药物。 A third histamine receptor subtype was characterized in recent years. The H 3 receptors are presynaptic receptors which regulate the synthesis and release of histamine in histaminergic neurons in central nervous system. The subtype receptors also appear to occur on nonhistaminergic axon terminals, regulating release of other important neurotransmitters. Various agonists and antagonists of the subtype are reviewed. So far there have not been H 3 receptor ligands in therapeutic uses. However, a wide range of central effects following H 3 receptor stimulation or blockade has been described by various experimental studies. It is hoped that some novel histaminergic drugs will be developed in the future. [
作者 嵇汝运
出处 《药学服务与研究》 CAS CSCD 2004年第3期183-187,共5页 Pharmaceutical Care and Research
关键词 组胺H3受体 配体新药 突触前受体 受体激动剂 受体拮抗剂 histamine H_3 receptors presynaptic receptors H_3 receptor agonists H_3 receptor antagonists H_4 receptors
  • 相关文献

参考文献24

  • 1[1]Schwartz JC, Arrang JM, Garbarg M, et al. A third histamine receptor subtype: characterization, localization and functions of the H3-receptor[J]. Agents Actions, 1990, 30(1): 13.
  • 2[2]Van der Werf JF, Timmerman H. The histamine H3-receptor: a general presynaptic histaminergic regulatory system[J]? Trends Pharmacol Sci, 1989, 10(4): 154.
  • 3[3]Hey JA, Aslanian R, Bolser DC, et al. Studies on the pharmacology of the novel H3 receptor agonist. Sch 50971[J]. Arzneimittel-Forschung, 1998, 48(9): 881.
  • 4[4]Vollinga RC, Koning JP, Jansen FP, et al. A new potent and selective histamine H3 receptor agonist immepip (vuf4708)[J]. J Med Chem, 1994, 37(3): 332.
  • 5[5]Sasse A, Stark H, Reidemeister S, et al. Novel partial agonists for the histamine H3 receptor with high in vitro and in vivo activity[J]. J Med Chem, 1999, 42(20): 4269.
  • 6[6]Kazuta Y, Hirano K, Nitsume K. Cyclopropane based conformational restriction of histamine, (1s, 2 s)2-(2-aminoethyl )-( 1H-imidazol-4-yl ) cyclopropane, a highly restricted agonist for the histamine H3 receptor, having a cyclopropane structure[J]. J Med Chem, 2003, 46(10):1980.
  • 7[7]Tozer M J, Kallindjian SB. Histamine H3 receptor antagonists[J]. Exp()pinTher Pat, 2000, 10(7): 1045.
  • 8[8]McLeod RL, Rizzo CA, West RE, et al. Pharmacological characterization of the novel histamine H3-receptor antagonist N- ( 3, 5-dichlorophenyl )-N' [[ 4- ( 1H-imidazol-4-yl-methyl )phenyl]methyl]-urea (Sch 79687)[J]. J Pharmacol Exp Ther, 2003, 305(3): 1037.
  • 9[9]Clitherow JW, Beswick P, Irving WJG, et al. Novel 1,2,4-oxadiazoles as potent and selective histamine H3-receptor antagonists[J]. Bioorg Med Chem Lett, 1996, 6(7): 833.
  • 10[10]Ali SM, Tedford CE, Gregory R, et al. New acetylene based histamine H3-receptor antagonists derived from the marine natural product verengamine[J]. Bioorg Med Chem Lett,1998, 8(10): 1133.

同被引文献29

  • 1KITBUNNADAJ R,ZUIDERVELD O P,CHRISTOPHE B,et al.Identification of 4-[1H-imidazol-4(5)-ylmethyl]pyridine(immethridine)as a novel,potent,and highly selective histamine H3 receptor agonist[J].J Med Chem,2004,47(10):2414-2417.
  • 2KITBUNNADAJ R,HASHIMOTO T,POLI E,et al.N-substituted piperidinyl alkyl imidazoles:discovery of methimepip as a potent and selective histamine H3 receptor agonist[J].J Med Chem,2005,48(6):2100-2107.
  • 3NAKAYA M,FUKUSHIMA Y,TAKEUCHI N,et al.Nasal allergie response mediated by histamine H3 receptors in murine allegic rhinitis[J].Laryngoscope,2005,115(10):1778-1784.
  • 4HANCOCK A A,BENNANI Y L,BUSH E N,et al.Antiobesity effects of A-331440,a novel non-imidazole histamine H3 receptor antagonist[J].Eur J Pharmacol,2004,487(1-3):183-197.
  • 5MOR M,BORDI F,SILVA C,et al.Synthesis,biological activity.QSAR and QSPR study of 2-aminobenzimidazole derivatives as potent H3-antagonists[J].Bioorg Med Chem,2004,12(4):663-674.
  • 6GRASSMANN S,APEIJT J,SIPPL W,et al.Histamine N-methyltransferase potencies and histamine Hh3 receptor affinities[J].Bioorg Med Chem,2003,11(10):2163-2174.
  • 7BERTINARIA M,STILO A D,TOSCO P,et al.[3-(1H-Imidazol-4-yl)propyl]guanidines containing furoxan moieties:a New class of H3-antagonists endowed with NO-donor properties[J].Bioorg Med Chern,2003,11(7):1197-1205.
  • 8TOSCO P.BERTINARIA M,STILO A D,et al.Furoxan analogues of the histamine H3-receptor antagonist imoproxifan and related furazan derivatives[J].Bioorg Med Chem,2005,13(15):4750-4759.
  • 9TOSCO P,BERTINARIA M,STILO A D,et al.Non-imidazole histamine NO-donor H3-antagonists[J].Farmaco,2005,60(6-7):507-512.
  • 10WALCZYNSKI K,ZUIDERVELD O P,TIMMERMAN H.Nonimidazole histamine H3 ligands.Part Ⅲ.New 4-N-propylpiperazincs as non-imidazole histamine H3-antagonists[J].Eur J Med Chem,2005,40(1):15-23.

引证文献1

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部